183 related articles for article (PubMed ID: 33801766)
1. Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients.
Yoon HG; Ahn YC; Oh D; Noh JM; Park SG; Nam H; Ju SG; Kwon D; Park S
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33801766
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
3. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
[TBL] [Abstract][Full Text] [Related]
4. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Bhangoo RS; DeWees TA; Yu NY; Ding JX; Liu C; Golafshar MA; Rule WG; Vora SA; Ross HJ; Ahn DH; Beamer SE; Jaroszewski DE; Hallemeier CL; Liu W; Ashman JB; Sio TT
Adv Radiat Oncol; 2020; 5(5):871-879. PubMed ID: 33083649
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
6. Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer.
Park SG; Ahn YC; Oh D; Noh JM; Ju SG; Kwon D; Jo K; Chung K; Chung E; Lee W; Park S
Cancer Sci; 2019 Sep; 110(9):2867-2874. PubMed ID: 31237050
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.
Blanchard P; Garden AS; Gunn GB; Rosenthal DI; Morrison WH; Hernandez M; Crutison J; Lee JJ; Ye R; Fuller CD; Mohamed AS; Hutcheson KA; Holliday EB; Thaker NG; Sturgis EM; Kies MS; Zhu XR; Mohan R; Frank SJ
Radiother Oncol; 2016 Jul; 120(1):48-55. PubMed ID: 27342249
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus.
Mohiuddin JJ; Jethwa KR; Grandhi N; Breen WG; Wang X; Anvari A; Lin H; Sandhyavenu H; Doucette A; Plastaras JP; Rule WG; Metz JM; Merrell KW; Sio TT; Ashman JB; Haddock MG; Ben-Josef E; Hallemeier CL; Wojcieszynski AP
Adv Radiat Oncol; 2021; 6(5):100744. PubMed ID: 34646965
[TBL] [Abstract][Full Text] [Related]
9. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.
Yu NY; DeWees TA; Liu C; Daniels TB; Ashman JB; Beamer SE; Jaroszewski DE; Ross HJ; Paripati HR; Rwigema JM; Ding JX; Shan J; Liu W; Schild SE; Sio TT
Adv Radiat Oncol; 2020; 5(3):450-458. PubMed ID: 32529140
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
Manzar GS; Lester SC; Routman DM; Harmsen WS; Petersen MM; Sloan JA; Mundy DW; Hunzeker AE; Amundson AC; Anderson JL; Patel SH; Garces YI; Halyard MY; McGee LA; Neben-Wittich MA; Ma DJ; Frank SJ; Whitaker TJ; Foote RL
Radiother Oncol; 2020 Jun; 147():64-74. PubMed ID: 32234612
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chang CL; Lin KC; Chen WM; Shia BC; Wu SY
J Thorac Oncol; 2024 May; 19(5):818-828. PubMed ID: 38154513
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
13. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.
Thaker NG; Boyce-Fappiano D; Ning MS; Pasalic D; Guzman A; Smith G; Holliday EB; Incalcaterra J; Garden AS; Shaitelman SF; Gunn GB; Fuller CD; Blanchard P; Feeley TW; Kaplan RS; Frank SJ
Int J Part Ther; 2021; 8(1):374-382. PubMed ID: 34285963
[TBL] [Abstract][Full Text] [Related]
14. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Smith GL; Fu S; Ning MS; Nguyen DK; Busse PM; Foote RL; Garden AS; Gunn GB; Fuller CD; Morrison WH; Chronowski GM; Shah SJ; Mayo LL; Phan J; Reddy JP; Snider JW; Patel SH; Katz SR; Lin A; Mohammed N; Dagan R; Lee NY; Rosenthal DI; Frank SJ
Int J Part Ther; 2021; 8(1):319-327. PubMed ID: 34285958
[TBL] [Abstract][Full Text] [Related]
15. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
18. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
19. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
20. Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers.
Jain V; Irmen P; O'Reilly S; Vogel JH; Lin L; Lin A
Int J Part Ther; 2020; 6(4):1-10. PubMed ID: 32582814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
